Goldman Sachs’s Shockwave Medical SWAV Stock Holding History
Bought
Maintained
Sold
Other funds holding SWAV
Goldman Sachs's SWAV Position: Q2 2024 in Review
Goldman Sachs sold out of Shockwave Medical (SWAV) in Q2 2024, closing a stake of 179,235 shares — an estimated $58.4M sold.
Goldman Sachs first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $124M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.
- Goldman Sachs reported no remaining Shockwave Medical position as of Q2 2024 after selling out during the quarter.
- Goldman Sachs sold 179,235 Shockwave Medical shares in Q2 2024, an estimated $58.4M.
- Goldman Sachs first reported a position in Shockwave Medical in Q1 2019 and held it in 21 quarters.
- Goldman Sachs's Shockwave Medical position peaked at $124M in Q3 2022.
- 7 funds tracked by Wall St. Rank held Shockwave Medical as of Q2 2024.
Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.